
Some hospital executives and cancer researchers sit on the boards of publicly traded companies, raising questions about whether their dual roles create a conflict of interest.
By KATIE THOMAS and CHARLES ORNSTEIN from NYT Health https://nyti.ms/2EVPKoK
via IFTTT
Boards of Directors, Drugs (Pharmaceuticals)
Source The New York Times
Làm đẹp Blog 247
Không có nhận xét nào:
Đăng nhận xét